IL330343A - טיפול במחלת ריאות חסימתית כרונית באמצעות נוגדן נגד tslp - Google Patents
טיפול במחלת ריאות חסימתית כרונית באמצעות נוגדן נגד tslpInfo
- Publication number
- IL330343A IL330343A IL330343A IL33034326A IL330343A IL 330343 A IL330343 A IL 330343A IL 330343 A IL330343 A IL 330343A IL 33034326 A IL33034326 A IL 33034326A IL 330343 A IL330343 A IL 330343A
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- pulmonary disease
- chronic obstructive
- obstructive pulmonary
- tslp antibody
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202463618273P | 2024-01-05 | 2024-01-05 | |
| PCT/US2025/010264 WO2025147632A1 (en) | 2024-01-05 | 2025-01-03 | Treatment of chronic obstructive pulmonary disease with anti-tslp antibody |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL330343A true IL330343A (he) | 2026-08-01 |
Family
ID=94637262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL330343A IL330343A (he) | 2024-01-05 | 2025-01-03 | טיפול במחלת ריאות חסימתית כרונית באמצעות נוגדן נגד tslp |
Country Status (4)
| Country | Link |
|---|---|
| AU (1) | AU2025205852A1 (he) |
| IL (1) | IL330343A (he) |
| TW (1) | TW202544036A (he) |
| WO (1) | WO2025147632A1 (he) |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| ES2246502T3 (es) | 1990-08-29 | 2006-02-16 | Genpharm International, Inc. | Animales no humanos transgenicos capaces de producir anticuerpos heterologos. |
| US7982016B2 (en) | 2007-09-10 | 2011-07-19 | Amgen Inc. | Antigen binding proteins capable of binding thymic stromal lymphopoietin |
| US8359965B2 (en) | 2007-09-17 | 2013-01-29 | Oxford J Craig | Apparatus and method for broad spectrum radiation attenuation |
| AR082163A1 (es) | 2010-07-15 | 2012-11-14 | Hoffmann La Roche | Anticuerpos especificamente ligantes del tslpr humano y metodos de utilizacion de los mismos |
| AT510032B1 (de) | 2010-11-30 | 2012-01-15 | Steiner Erwin Ing | Montageeinrichtung für fassadenelemente |
| US9100245B1 (en) | 2012-02-08 | 2015-08-04 | Amazon Technologies, Inc. | Identifying protected media files |
| US9306926B2 (en) | 2013-03-15 | 2016-04-05 | Brian A. Truong | User authentication using unique hidden identifiers |
| CA3066399A1 (en) | 2017-06-08 | 2018-12-13 | Amgen Inc. | Torque driven drug delivery device |
| IL319987A (he) | 2017-11-10 | 2025-06-01 | Amgen Inc | בוכנות עבור התקני מתן תרופה |
| WO2019100111A1 (en) | 2017-11-21 | 2019-05-31 | Monash University | Methods of treating and diagnosing conditions |
| WO2019178151A1 (en) | 2018-03-13 | 2019-09-19 | Amgen Inc. | Methods for the preparation of trypsin-resistant polypeptides for mass spectrometric analysis |
| JP7719714B2 (ja) | 2018-10-15 | 2025-08-06 | アムジエン・インコーポレーテツド | ダンピング機構を有する薬物送達装置 |
| MA53913A (fr) | 2018-10-15 | 2022-01-19 | Amgen Inc | Procédé d'assemblage de plate-forme pour dispositif d'administration de médicament |
| TWI917325B (zh) | 2019-06-04 | 2026-03-11 | 大陸商江蘇恆瑞醫藥股份有限公司 | 能結合胸腺基質淋巴細胞生成素的抗體及其應用 |
| JP7331298B2 (ja) | 2019-09-04 | 2023-08-23 | ビオシオン インコーポレイテッド | 抗体結合ｔｓｌｐ及びその使用 |
| CN114887053B (zh) | 2019-11-29 | 2026-04-24 | 康诺亚生物医药科技（成都）有限公司 | 一种tslp相关病症治疗剂的开发和应用 |
| EP4047019A4 (en) | 2019-12-13 | 2023-11-15 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Anti-tslp antibody and uses thereof |
| TW202140550A (zh) | 2020-01-29 | 2021-11-01 | 瑞士商諾華公司 | 使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法 |
| CN111171150B (zh) | 2020-02-05 | 2020-12-08 | 北京智仁美博生物科技有限公司 | 抗人tslp抗体及其用途 |
| CN111196850B (zh) | 2020-02-07 | 2020-10-30 | 北京汇智和源生物技术有限公司 | 人胸腺基质淋巴细胞生成素单克隆抗体及其应用 |
| CN114437212B (zh) | 2020-11-06 | 2023-03-14 | 上海麦济生物技术有限公司 | 抗人胸腺基质淋巴细胞生成素抗体及其制备方法和应用 |
| WO2022117079A1 (zh) | 2020-12-03 | 2022-06-09 | 江苏恒瑞医药股份有限公司 | 结合胸腺基质淋巴细胞生成素的抗体及其应用 |
| MX2023006596A (es) | 2020-12-03 | 2023-06-19 | Jiangsu Hengrui Pharmaceuticals Co Ltd | Composicion farmaceutica de anticuerpo anti-tslp y uso de la misma. |
| CN113501878B (zh) | 2021-02-03 | 2022-12-02 | 北京智仁美博生物科技有限公司 | 针对人tslp的多种抗体及其用途 |
| WO2022166739A1 (en) | 2021-02-04 | 2022-08-11 | Staidson (Beijing) Biopharmaceuticals Co., Ltd. | Antibodies specifically recognizing thymic stromal lymphopoietin and uses thereof |
| CN114853888B (zh) | 2021-02-05 | 2023-11-03 | 上海洛启生物医药技术有限公司 | 抗tslp纳米抗体及其应用 |
| TWI915520B (zh) | 2021-03-03 | 2026-02-21 | 大陸商正大天晴藥業集團股份有限公司 | 含抗tslp抗體的藥物組合物 |
| US20240190951A1 (en) | 2021-04-23 | 2024-06-13 | Amgen Inc. | Anti-tslp antibody compositions and uses thereof |
| KR20230175245A (ko) | 2021-04-23 | 2023-12-29 | 암젠 인크 | 변형된 항-tslp 항체 |
| CN115433275B (zh) | 2021-06-02 | 2026-02-24 | 启愈生物技术(上海)有限公司 | 抗胸腺基质淋巴细胞生成素（tslp）抗体及其用途 |
| WO2023070948A1 (zh) | 2021-11-01 | 2023-05-04 | 江苏荃信生物医药股份有限公司 | 包含抗人胸腺基质淋巴细胞生成素(tslp)单克隆抗体的浓缩溶液的制备方法及液体制剂 |
| CN117209604B (zh) | 2021-12-02 | 2024-03-22 | 北京东方百泰生物科技股份有限公司 | 一种抗tslp的单克隆抗体、其抗原结合片段及其应用 |
| CA3244178A1 (en) | 2021-12-24 | 2023-06-29 | Inmagene Pte. Ltd. | NEW ANTI-TSLP ANTIBODY |
-
2025
- 2025-01-03 IL IL330343A patent/IL330343A/he unknown
- 2025-01-03 TW TW114100284A patent/TW202544036A/zh unknown
- 2025-01-03 AU AU2025205852A patent/AU2025205852A1/en active Pending
- 2025-01-03 WO PCT/US2025/010264 patent/WO2025147632A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| TW202544036A (zh) | 2025-11-16 |
| WO2025147632A1 (en) | 2025-07-10 |
| AU2025205852A1 (en) | 2026-07-09 |